These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8752154)

  • 21. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.
    Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y
    Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells.
    Arthur G; Samadder P; Bittman R
    Anticancer Res; 2005; 25(1A):95-100. PubMed ID: 15816524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
    Wu Q; Kiguchi K; Kawamoto T; Ajiki T; Traag J; Carbajal S; Ruffino L; Thames H; Wistuba I; Thomas M; Vasquez KM; DiGiovanni J
    Cancer Res; 2007 Apr; 67(8):3794-800. PubMed ID: 17440093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites.
    Ferrari S; Pearson RB; Siegmann M; Kozma SC; Thomas G
    J Biol Chem; 1993 Aug; 268(22):16091-4. PubMed ID: 8344891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites.
    Han JW; Pearson RB; Dennis PB; Thomas G
    J Biol Chem; 1995 Sep; 270(36):21396-403. PubMed ID: 7545671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis.
    Thomas G
    Biochem Soc Trans; 1993 Nov; 21(4):901-4. PubMed ID: 8132090
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin.
    Jaster R; Bittorf T; Klinken SP; Brock J
    Biochem Pharmacol; 1996 May; 51(9):1181-5. PubMed ID: 8645341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Drosophila p70s6k homolog exhibits conserved regulatory elements and rapamycin sensitivity.
    Stewart MJ; Berry CO; Zilberman F; Thomas G; Kozma SC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10791-6. PubMed ID: 8855259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.
    Pearson RB; Dennis PB; Han JW; Williamson NA; Kozma SC; Wettenhall RE; Thomas G
    EMBO J; 1995 Nov; 14(21):5279-87. PubMed ID: 7489717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.
    Terada N; Patel HR; Takase K; Kohno K; Nairn AC; Gelfand EW
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11477-81. PubMed ID: 7972087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental studies of the biology of human small cell lung cancer.
    Carney DN; Broder L; Edelstein M; Gazdar AF; Hansen M; Havemann K; Matthews MJ; Sorenson GD; Videløv L
    Cancer Treat Rep; 1983 Jan; 67(1):27-35. PubMed ID: 6311411
    [No Abstract]   [Full Text] [Related]  

  • 33. Constitutive activation of p70S6k in cancer cells.
    Kwon HK; Bae GU; Yoon JW; Kim YK; Lee HY; Lee HW; Han JW
    Arch Pharm Res; 2002 Oct; 25(5):685-90. PubMed ID: 12433206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin-resistant human lymphoid cell lines.
    Kay JE; Wellhausen A; Frost V; Morgan GY; Smith MC; Morley SJ
    Biochem Soc Trans; 1996 Feb; 24(1):89S. PubMed ID: 8674772
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapamycin resistance tied to defective regulation of p27Kip1.
    Luo Y; Marx SO; Kiyokawa H; Koff A; Massagué J; Marks AR
    Mol Cell Biol; 1996 Dec; 16(12):6744-51. PubMed ID: 8943329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus (rapamycin) inhibits mitogen-induced stimulation of protein synthesis in primary lymphocytes.
    Bansbach CC; Wancio D; Sehgal SN
    Inflamm Res; 1995 Aug; 44 Suppl 2():S179-80. PubMed ID: 8548386
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapamycin throws a master switch.
    Josephson J
    Environ Health Perspect; 2003 May; 111(6):A335. PubMed ID: 12790142
    [No Abstract]   [Full Text] [Related]  

  • 38. Migrastatin, a novel 14-membered ring macrolide, inhibits anchorage-independent growth of human small cell lung carcinoma Ms-1 cells.
    Takemoto Y; Nakae K; Kawatani M; Takahashi Y; Naganawa H; Imoto M
    J Antibiot (Tokyo); 2001 Dec; 54(12):1104-7. PubMed ID: 11858668
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible isomerization of rapamycin demonstrated by liquid chromatography.
    Nishikawa T; Suzuki S; Ohtani H
    J Antibiot (Tokyo); 1994 Dec; 47(12):1554-6. PubMed ID: 7844050
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of Signalling Pathways That Link Apoptosis and Autophagy to Cell Death Induced by Estrone Analogues Which Reversibly Depolymerize Microtubules.
    Mercier AE; Prudent R; Pepper MS; De Koning L; Nolte E; Peronne L; Nel M; Lafanechère L; Joubert AM
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33572896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.